We are live on ! Find out more
CI

Clal Insurance Portfolio holdings

AUM $22.3B
1-Year Est. Return 79.91%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+79.91%
3 Year Est. Return
+201.85%
5 Year Est. Return
+220.25%
10 Year Est. Return
+954.66%
AUM
$3.93B
AUM Growth
+$505M
Cap. Flow
+$516M
Cap. Flow %
13.12%
Top 10 Hldgs %
47%
Holding
107
New
10
Increased
20
Reduced
24
Closed
4

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$68.5M
2
PRGO icon
Perrigo
PRGO
+$55.9M
3
CSCO icon
Cisco
CSCO
+$33.3M
4
GE icon
GE Aerospace
GE
+$31.9M
5
STLD icon
Steel Dynamics
STLD
+$26.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 75.31%
2 Healthcare 10.25%
3 Financials 4.97%
4 Technology 3.04%
5 Utilities 2.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLT icon
76
Allot
ALLT
$399M
$2.68M 0.07%
+544,840
New +$2.73M
SPNS
77
DELISTED
Sapiens International
SPNS
$2.63M 0.07%
224,632
ICL icon
78
ICL Group
ICL
$7.2B
$2.54M 0.06%
649,982
CSCO icon
79
Cisco
CSCO
$434B
$2.17M 0.06%
75,800
-1,187,745
-94% -$33.3M
GDX icon
80
VanEck Gold Miners ETF
GDX
$28.3B
$2M 0.05%
72,000
POT
81
DELISTED
Potash Corp Of Saskatchewan
POT
$1.95M 0.05%
+119,800
New +$2M
CVS icon
82
CVS Health
CVS
$121B
$1.92M 0.05%
20,000
+10,000
+100% +$997K
NVS icon
83
Novartis
NVS
$263B
$1.41M 0.04%
19,039
IYT icon
84
iShares US Transportation ETF
IYT
$2.1B
$1.35M 0.03%
40,368
CEL
85
DELISTED
Cellcom Israel, Ltd.
CEL
$1.3M 0.03%
197,526
AAPL icon
86
Apple
AAPL
$4.84T
$1.29M 0.03%
54,000
+35,600
+193% +$885K
WBA
87
DELISTED
Walgreens Boots Alliance
WBA
$1.03M 0.03%
12,400
JNK icon
88
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.78B
$619K 0.02%
5,777
IHF icon
89
iShares US Healthcare Providers ETF
IHF
$1.32B
$603K 0.02%
23,685
-19,750
-45% -$495K
SCHE icon
90
Schwab Emerging Markets Equity ETF
SCHE
$12.7B
$431K 0.01%
20,248
+169
+0.8% +$3.47K
CORP icon
91
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.33B
$422K 0.01%
3,972
DBUK
92
DELISTED
Xtrackers MSCI United Kingdom Hedged Equity ETF
DBUK
$160K ﹤0.01%
7,013
EMLC icon
93
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$5.07B
$152K ﹤0.01%
4,025
XRT icon
94
State Street SPDR S&P Retail ETF
XRT
$395M
$144K ﹤0.01%
3,440
HYG icon
95
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
$53K ﹤0.01%
624
+144
+30% +$12K
VGK icon
96
Vanguard FTSE Europe ETF
VGK
$30.1B
$39K ﹤0.01%
841
DBEU icon
97
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$768M
$18K ﹤0.01%
718
PJT icon
98
PJT Partners
PJT
$3.97B
$18K ﹤0.01%
782
ACWI icon
99
iShares MSCI ACWI ETF
ACWI
$32.7B
$12K ﹤0.01%
220
-80
-27% -$4.51K
PFF icon
100
iShares Preferred and Income Securities ETF
PFF
$12.6B
$5K ﹤0.01%
126

Similar funds

Clal Insurance's Q2 2016 Portfolio in Review

As of Q2 2016, Clal Insurance held 107 positions worth $3.93B, up 15% from $3.43B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Clal Insurance deployed $516M of net new capital in Q2 2016, opening 10 new positions and adding to 20 existing holdings. Its largest new stake was Xtrackers MSCI Japan Hedged Equity ETF: 9,132,763 shares worth $281M.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 64% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $68.5M trimmed.

  • Clal Insurance's largest Q2 2016 buy was Xtrackers MSCI Japan Hedged Equity ETF: 9,132,763 shares worth $281M.
  • Clal Insurance added most to iShares MSCI Emerging Markets ETF in Q2 2016, an estimated $198M increase.
  • Clal Insurance's biggest Q2 2016 reduction was Teva Pharmaceuticals, cutting an estimated $68.5M.
  • Clal Insurance fully exited Check Point Software Technologies in Q2 2016, selling an estimated $16.8M.
  • Clal Insurance's ten largest holdings make up 47% of its $3.93B portfolio in Q2 2016.
  • Clal Insurance opened 10 new positions and closed 4 in Q2 2016.
  • Clal Insurance's portfolio value rose 15% quarter-over-quarter to $3.93B.

Based on Clal Insurance's 13F filing for Q2 2016, filed 8 Aug 2016.